SEE
56
6
ROST
63
12
TRIP
47
3
MHK
49
4
IBM
58
-2
TROW
56
5
CINF
53
2
GE
67
2
PAYX
53
2
CSCO
67
4
MAT
46
12
PBI
69
4
CHRW
56
-3
SIG
52
3
UPS
60
9
DOW
44
10
ORLY
62
2
ILMN
42
5
KLAC
47
4
APD
59
2
SEE
56
6
ROST
63
12
TRIP
47
3
MHK
49
4
IBM
58
-2
TROW
56
5
CINF
53
2
GE
67
2
PAYX
53
2
CSCO
67
4
MAT
46
12
PBI
69
4
CHRW
56
-3
SIG
52
3
UPS
60
9
DOW
44
10
ORLY
62
2
ILMN
42
5
KLAC
47
4
APD
59
2
Financhill
Back

Kiniksa Pharmaceuticals International PLC Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
41

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
21.30
Seasonality Move:
39.39%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA) is a Sell

Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?

  • The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.28. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • KNSA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KNSA Stock Price Chart

What is Kiniksa Pharmaceuticals International PLC's stock price today?

  • The Kiniksa Pharmaceuticals International PLC share price today is $21.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

KNSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 36.27 Sell
Chaikin Money Flow: -19243 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.15 - 25.47) Sell
Bollinger Bands (100): (22.24 - 26.48) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

KNSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Sell
20-day SMA: 22.45 Sell
50-day SMA: 24.26 Sell
200-day SMA: 21.8 Sell
8-day EMA: 21.53 Sell
20-day EMA: 22.5 Sell
50-day EMA: 23.6 Sell
200-day EMA: 22.03 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.89 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Kiniksa Pharmaceuticals International PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):